The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Astera Labs Inc (NASDAQ: ALAB) closed at $181.94 up 1.47% from its previous closing price of $179.31. In other words, the price has increased by $1.47 from its previous closing price. On the day, 9.32 million shares were traded. ALAB stock price reached its highest trading level at $191.4 during the session, while it also had its lowest trading level at $172.72.
Ratios:
For a deeper understanding of Astera Labs Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 131.81. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, TD Cowen on November 05, 2025, Reiterated its Hold rating but revised its target price to $170 from $225 previously.
On November 05, 2025, Stifel reiterated its Buy rating and also lowered its target price recommendation from $185 to $200.
Needham reiterated its Buy rating for the stock on November 05, 2025, while the target price for the stock was revised from $205 to $220.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 01 ’25 when Mazzara Philip sold 10,000 shares for $192.16 per share. The transaction valued at 1,921,572 led to the insider holds 151,573 shares of the business.
ALBA MANUEL sold 183,000 shares of ALAB for $31,707,713 on Sep 02 ’25. The Director now owns 385,863 shares after completing the transaction at $173.27 per share. On Aug 28 ’25, another insider, Mazzara Philip, who serves as the General Counsel and Secretary of the company, sold 10,000 shares for $188.70 each. As a result, the insider received 1,886,956 and left with 161,573 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 30730323968 and an Enterprise Value of 28771973120. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 162.62, and their Forward P/E ratio for the next fiscal year is 76.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 41.83 while its Price-to-Book (P/B) ratio in mrq is 26.63. Its current Enterprise Value per Revenue stands at 47.514 whereas that against EBITDA is 616.802.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.48, which has changed by 0.8976611 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is -7.54%, while the 200-Day Moving Average is calculated to be 50.74%.
Shares Statistics:
For the past three months, ALAB has traded an average of 6.14M shares per day and 5254660 over the past ten days. A total of 166.22M shares are outstanding, with a floating share count of 130.24M. Insiders hold about 21.64% of the company’s shares, while institutions hold 62.54% stake in the company. Shares short for ALAB as of 1760486400 were 9260453 with a Short Ratio of 1.51, compared to 1757894400 on 9621313. Therefore, it implies a Short% of Shares Outstanding of 9260453 and a Short% of Float of 7.580000000000001.
Earnings Estimates
The stock of Astera Labs Inc (ALAB) is currently being evaluated by 14.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.5, with high estimates of $0.55 and low estimates of $0.42.
Analysts are recommending an EPS of between $1.78 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.31, with 18.0 analysts recommending between $2.88 and $1.8.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $243.84M this quarter.It ranges from a high estimate of $250.5M to a low estimate of $214.8M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 12 analysts are estimating revenue of $252.63M. There is a high estimate of $262.7M for the next quarter, whereas the lowest estimate is $219.1M.
A total of 17 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $832.5M, while the lowest revenue estimate was $772.6M, resulting in an average revenue estimate of $816.66M. In the same quarter a year ago, actual revenue was $396.29MBased on 16 analysts’ estimates, the company’s revenue will be $1.14B in the next fiscal year. The high estimate is $1.29B and the low estimate is $972.5M.
